API

Active Pharmaceutical Ingredients (API), popularly speaking, are the raw materials of medicines, only pharmaceutical raw materials are processed into pharmaceutical preparations , can they become medicines available for clinical use, so drugs we usually eat are the finished drugs through processing. Active Pharmaceutical Ingredients based on its sources can be divided into two major categories ,including chemical synthetic drugs and natural chemical drugs. Chemical synthetic drugs can be divided into organic synthetic drugs and inorganic synthetic drugs. Inorganic synthetic drugs are inorganic compounds ( very few is element), such as aluminum hydroxide, magnesium trisilicate which are used for the treatment of gastric and duodenal ulcers ; organic synthetic drugs are mainly composed of drugs made by basic organic chemical raw materials, through a series of organic chemical reactions (such as aspirin, chloramphenicol, caffeine, etc.). Natural chemical drugs ,based on its sources,can be divided into two categories including biochemical drugs and plant chemical drugs. Antibiotics are generally made by the microbial fermentation, which belongs to the biochemistry category. A variety of semi-synthetic antibiotics occurs in recent years,which are biosynthesis and chemical synthesis combining products.Among active Pharmaceutical Ingredients, the organic synthetic drugs varieties, yields and values have the largest proportion,which are the main pillars of the chemical and pharmaceutical industries. The quality of active Pharmaceutical Ingredients decides whether the formulation is good or bad , so its quality standards are very strict ,countries in the world have developed national pharmacopoeia standards and strict quality control methods for its widely used active Pharmaceutical ingredients.

Vitreous or Amorphous Silica

High-purity amorphous or fused silica, also called vitreous silica, when optically translucent is a high-performance ceramic obtained by electrothermal fusion of high-grade silica sand with a silica c

Jan 9,2024  API

Polymorphs of silica (SiO2 )

SiO2 exhibits a complex polymorphism characterised by the occurrence of a large number of reversible and irreversible phase transformations usually associated with important relative volume changes (Δ

Jan 9,2024  API

The synthesis method of Ubrogepant

Ubrogepant is a first-in-class oral calcitonin gene-related peptide (CGRP) receptor antagonist that Allergen developed under license from Merck & Co.

Jan 9,2024  API

The introduction of Mirogabalin besylate

Mirogabalin besylate is a member of the gabapentinoid drug class, which includes gabapentin (Neurotin) and pregabalin (Lyrica).

Jan 9,2024  API

Brexpiprazole: Effective and Well-Tolerated Treatment in Schizophrenia Patients

Brexpiprazole is an effective and well-tolerated treatment option for acute schizophrenia and maintenance treatment in adults.

Jan 9,2024  API

Colchicine: A Versatile Anti-Inflammatory Medication for Cardiovascular Disease

Colchicine has shown clinical efficacy in the treatment of pericardial disease and atrial fibrillation, with common side effects including gastrointestinal intolerance and myalgias.

Jan 9,2024  API

Tetrahydro-4H-pyran-4-one: Synthesis and Potential Pharmaceutical Applications

Tetrahydro-4H-pyran-4-one is synthesized using various reagents and solvents, and has pharmaceutical applications as an SSAO inhibitor and a modulator of NMDA receptors.

Jan 9,2024  API

Acyclovir: Antiviral Medication for Herpes with Promising Pharmacokinetics and Potency

Acyclovir treats viral infections. Oral absorption is limited with peak plasma concentrations of 0.5 μg/ml. Dosages vary by indication.

Jan 9,2024  API

Cinnamic Acid: Dietary Sources, Mechanisms of Action and New Formulation

Cinnamic acid in plant-based foods stimulates insulin secretion, but its limited bioavailability led to new formulations like nanoparticles for improved effectiveness against chronic diseases.

Jan 9,2024  API

Understanding the Mechanism, Pharmacokinetics, and Side Effects of Prednisolone

Prednisolone binds to glucocorticoid receptors, with 70% bioavailability. Metabolism involves prednisone conversion. Overdose causes side effects.

Jan 9,2024  API
Prev12345678910...Next>  Go to Page